Stay updated on Concurrent VRP-HER2 & Pembrolizumab in Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Concurrent VRP-HER2 & Pembrolizumab in Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Concurrent VRP-HER2 & Pembrolizumab in Breast Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page's revision indicator was updated from v3.6.4 to v3.6.5, signaling a minor update to the page's metadata. This change does not modify the study information presented.
    Difference
    0.1%
    Check dated 2026-08-10T12:43:04.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The site’s revision label was updated from v3.6.3 to v3.6.4, reflecting a new build of the page. There were no visible changes to the study details or navigation.
    Difference
    0.1%
    Check dated 2026-07-27T06:35:42.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.3, replacing Revision: v3.6.2, indicating a minor update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-07-05T14:25:29.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.0 to v3.6.2, indicating a minor update to the page's documentation or underlying system. This does not modify visible study details or user-facing information.
    Difference
    0.1%
    Check dated 2026-06-28T08:16:02.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    New sections How to Read a Study Record, Common Questions, and How to Join a Study were added. The page now shows recruitment status as No longer looking for participants and the revision label updated to v3.6.0, with a formatting change from Intervention / Treatment to Intervention/Treatment.
    Difference
    0.5%
    Check dated 2026-06-14T05:18:19.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Enrollment-related status updates are now shown for the study, including an Enrollment issue and a Terminated designation with corresponding dates. These changes reflect shifts in recruitment status and the overall study activity.
    Difference
    0.5%
    Check dated 2026-06-07T00:12:51.000Z thumbnail image

Stay in the know with updates to Concurrent VRP-HER2 & Pembrolizumab in Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Concurrent VRP-HER2 & Pembrolizumab in Breast Cancer Clinical Trial page.